This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 9, No 3 (2020): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15540, first published .
Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

Authors of this article:

Jacqui McCoy1 Author Orcid Image ;   Suzanne Nielsen2 Author Orcid Image ;   Raimondo Bruno1 Author Orcid Image
Article Authors Cited by (3) Tweetations (3) Metrics

Journals

  1. McCoy J, Nielsen S, Bruno R. A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine. Addiction 2022;117(3):677 View
  2. Dunn A, Wu N, Cordaro F. Management of loperamide‐related opioid use disorder with buprenorphine within an Australian context: A case report. Drug and Alcohol Review 2024;43(6):1645 View
  3. Maher J, McCoy J, Bruno R, Nielsen S. The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study. International Journal of Clinical Pharmacy 2024;46(5):1181 View